MET and colorectal cancer: Aberrant HGF/HGFR activation has been observed in many solid tumor types (including hepatocellular, pancreatic ductal, and colorectal cancers), and promotes cellular proliferation and metastasis via growth factor and other oncogenic receptors [8].